Antibiotic Susceptibility Report of Bacteria Isolated From Blood Cultures of Neutropenic Sepsis Patients Undergoing Chemotherapy
- PMID: 40656248
- PMCID: PMC12255959
- DOI: 10.7759/cureus.85903
Antibiotic Susceptibility Report of Bacteria Isolated From Blood Cultures of Neutropenic Sepsis Patients Undergoing Chemotherapy
Abstract
Background Febrile neutropenia often occurs as a serious complication in patients receiving chemotherapy. It is regarded as an oncologic emergency due to its high morbidity and mortality, necessitating the prompt initiation of empirical antibiotic therapy. While gram-negative bacteria have historically been the primary cause of bloodstream infections in febrile neutropenic patients, recent shifts in bacterial epidemiology and antimicrobial resistance patterns underscore the need for regular evaluation of local data to inform treatment strategies. Methods This retrospective cohort study was conducted in the Department of Hematology at Victoria Hospital, Kirkcaldy, from January to December 2024. It analyzed blood culture results, antibiotic use, chemotherapy regimens, patient characteristics, and microbial susceptibility patterns. A total of 63 patients with an absolute neutrophil count of less than 0.5 were selected through a simple convenience sampling method. Demographic data were collected from ward admission records using a standardized data collection sheet. Blood culture results were retrieved from the laboratory information management system and analyzed using IBM SPSS Statistics for Windows, Version 23.0 (Released 2015; IBM Corp., Armonk, NY, USA). Results Among the 63 patients, 20 (32%) had at least one positive blood culture, with a male-to-female ratio of 3:2. Gram-positive bacteria accounted for the majority of isolates (11; 55%), followed by gram-negative bacteria (eight; 40%), and mixed growth in one case (5%). Escherichia coli was the most common isolate (five; 25%), followed by Klebsiella species and Streptococcus viridans (four; 20% each). Staphylococcus epidermidis was identified in 3 cases (15%). The most common pathogens associated with line infections were S. epidermidis (three; 25%), S. viridans (three; 25%), and Klebsiella species (four; 33%). A statistically significant association was observed between the presence of a central venous line and the occurrence of bacteremia (p < 0.05). Most gram-negative isolates were susceptible to beta-lactam antibiotics and gentamicin, while gram-positive organisms showed high sensitivity to vancomycin and linezolid. Although gram-positive bacteria were the most frequently isolated organisms overall, E. coli was the single most common isolate and demonstrated susceptibility to the current first- and second-line antibiotics used in the treatment of neutropenic sepsis. Conclusions The findings of this study are broadly consistent with existing literature on bloodstream infections in neutropenic cancer patients, particularly in terms of the microbial spectrum and the association with central venous lines. However, variations in pathogen prevalence and antibiotic susceptibility may reflect local epidemiology or specific cohort characteristics. These results highlight the need to continually assess and update antibiotic guidelines to mitigate the development of drug-resistant strains, ensure adherence to current protocols, and improve the accuracy of empirical antibiotic prescribing.
Keywords: acute myeloid leukemia (aml); antibiotics; bacteria; cvc; e. coli; gram negative; gram positive; neutropenic sepsis; sensitivity.
Copyright © 2025, Musbau et al.
Conflict of interest statement
Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures



Similar articles
-
Prophylactic antibiotics for preventing gram-positive infections associated with long-term central venous catheters in adults and children receiving treatment for cancer.Cochrane Database Syst Rev. 2021 Oct 7;10(10):CD003295. doi: 10.1002/14651858.CD003295.pub4. Cochrane Database Syst Rev. 2021. PMID: 34617602 Free PMC article.
-
A single-center retrospective study of pathogen distribution and antibiotic resistance of bloodstream infections in emergency department.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Nov 28;49(11):1799-1807. doi: 10.11817/j.issn.1672-7347.2024.240333. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 40177763 Free PMC article. Chinese, English.
-
Antibiotic treatment for non-tuberculous mycobacteria lung infection in people with cystic fibrosis.Cochrane Database Syst Rev. 2025 Mar 27;3(3):CD016039. doi: 10.1002/14651858.CD016039. Cochrane Database Syst Rev. 2025. PMID: 40145528
-
Interventions to improve antibiotic prescribing practices for hospital inpatients.Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD003543. doi: 10.1002/14651858.CD003543.pub4. Cochrane Database Syst Rev. 2017. PMID: 28178770 Free PMC article.
-
Interventions to improve antibiotic prescribing practices for hospital inpatients.Cochrane Database Syst Rev. 2013 Apr 30;(4):CD003543. doi: 10.1002/14651858.CD003543.pub3. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2017 Feb 09;2:CD003543. doi: 10.1002/14651858.CD003543.pub4. PMID: 23633313 Updated.
References
-
- Neutropenic sepsis: prevention and management in people with cancer. [ Apr; 2025 ]. 2012. https://www.nice.org.uk/guidance/cg151 https://www.nice.org.uk/guidance/cg151 - PubMed
-
- Do we overtreat patients with presumed neutropenic sepsis? King A, Irvine S, McFadyen A, Isles C. Postgrad Med J. 2022;98:825–829. - PubMed
-
- Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Clin Infect Dis. 2003;36:1103–1110. - PubMed
-
- Sepsis in adult patients - definitions, epidemiology and economic aspects [Article in German] Moerer O, Quintel M. Internist (Berl) 2009;50:788, 790-4, 796-8. - PubMed
LinkOut - more resources
Full Text Sources